These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8094232)
1. Selective dopamine D-1 receptor agonists, SK&F 38393 and CY 208-243 reduce sucrose sham-feeding in the rat. Cooper SJ; Francis J; Barber DJ Neuropharmacology; 1993 Jan; 32(1):101-2. PubMed ID: 8094232 [TBL] [Abstract][Full Text] [Related]
2. The anorectic effect of SK&F 38393, a selective dopamine D1 receptor agonist: a microstructural analysis of feeding and related behaviour. Cooper SJ; Francis J; Rusk IN Psychopharmacology (Berl); 1990; 100(2):182-7. PubMed ID: 1968277 [TBL] [Abstract][Full Text] [Related]
3. New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243. Murray AM; Waddington JL Pharmacol Biochem Behav; 1990 Jan; 35(1):105-10. PubMed ID: 1969161 [TBL] [Abstract][Full Text] [Related]
4. The selective dopamine D1 receptor agonist SK&F 38393: its effects on palatability- and deprivation-induced feeding, and operant responding for food. Rusk IN; Cooper SJ Pharmacol Biochem Behav; 1989 Sep; 34(1):17-22. PubMed ID: 2576310 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus. Imperato A; Obinu MC; Gessa GL Brain Res; 1993 Aug; 618(2):341-5. PubMed ID: 8104086 [TBL] [Abstract][Full Text] [Related]
6. Dopamine D1 receptor family agonists, SK&F38393, SK&F77434, and SK&F82958, differentially affect locomotor activities in rats. Meyer ME; Shults JM Pharmacol Biochem Behav; 1993 Oct; 46(2):269-74. PubMed ID: 7903456 [TBL] [Abstract][Full Text] [Related]
7. CY 208-243 behaves as a typical D-1 agonist in the reserpine-treated mouse. Abbott B; Starr BS; Starr MS Pharmacol Biochem Behav; 1991 Feb; 38(2):259-63. PubMed ID: 1676166 [TBL] [Abstract][Full Text] [Related]
8. Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice. Winkler JD; Weiss B J Pharmacol Exp Ther; 1989 May; 249(2):507-16. PubMed ID: 2566677 [TBL] [Abstract][Full Text] [Related]
9. Locomotor activity following intra-accumbens microinjections of dopamine D1 agonist SK&F 38393 in rats. Meyer ME; Van Hartesveldt C; Potter TJ Synapse; 1993 Apr; 13(4):310-4. PubMed ID: 8097596 [TBL] [Abstract][Full Text] [Related]
10. Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat. Damsma G; Tham CS; Robertson GS; Fibiger HC Eur J Pharmacol; 1990 Sep; 186(2-3):335-8. PubMed ID: 1981190 [TBL] [Abstract][Full Text] [Related]
11. Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase. Downes RP; Waddington JL Eur J Pharmacol; 1993 Mar; 234(1):135-6. PubMed ID: 8097163 [TBL] [Abstract][Full Text] [Related]
12. Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist. Lovenberg TW; Brewster WK; Mottola DM; Lee RC; Riggs RM; Nichols DE; Lewis MH; Mailman RB Eur J Pharmacol; 1989 Jul; 166(1):111-3. PubMed ID: 2572425 [No Abstract] [Full Text] [Related]
13. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity. O'Boyle KM; Waddington JL Neuropharmacology; 1992 Feb; 31(2):177-83. PubMed ID: 1532443 [TBL] [Abstract][Full Text] [Related]
14. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys. Rosenzweig-Lipson S; Bergman J J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432 [TBL] [Abstract][Full Text] [Related]
16. Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents. Watts VJ; Lawler CP; Gilmore JH; Southerland SB; Nichols DE; Mailman RB Eur J Pharmacol; 1993 Sep; 242(2):165-72. PubMed ID: 7902811 [TBL] [Abstract][Full Text] [Related]
17. Synergistic and persistent interaction between the D2 agonist, bromocriptine, and the D1 selective agonist, CY 208-243. Robertson HA; Peterson MR; Worth GG Brain Res; 1992 Oct; 593(2):332-4. PubMed ID: 1360321 [TBL] [Abstract][Full Text] [Related]
18. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys. Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574 [TBL] [Abstract][Full Text] [Related]
19. Analysis of dopamine D1 and D2 receptor involvement in d- and l-amphetamine-induced anorexia in rats. Gilbert DB; Cooper SJ Brain Res Bull; 1985 Oct; 15(4):385-9. PubMed ID: 2933127 [TBL] [Abstract][Full Text] [Related]
20. Sucrose sham-feeding in the rat after administration of the selective dopamine D2 receptor agonist N-0437, d-amphetamine or cocaine. Cooper SJ; Rusk IN; Barber DJ Pharmacol Biochem Behav; 1989 Feb; 32(2):447-52. PubMed ID: 2567016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]